Company / Free Cash Flow per Share
InMed Pharmaceuticals Inc. Free Cash Flow per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$15.69
FY2025
5-year range
-$30.41 / -$2.24
FY2022-FY2025
Trend
-601.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -601% YoY in FY2025, a notable deviation from the 3-year average annual change of -163%.
Based on SEC 10-K filings.
-15.69 in FY2025.
Improved from $-24.01 to $-15.69 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 601.5% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$15.69 | -601.5% |
| FY2024 | -$2.24 | +90.7% |
| FY2023 | -$24.01 | +21.0% |
| FY2022 | -$30.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026